UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 130

Sortiert nach

Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis

The New England journal of medicine, 2017-06, Vol.376 (22), p.2122-2133

2017

Volltextzugriff (PDF)

Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"

Annals of neurology, 2005-12, Vol.58 (6), p.840-846

2005

Volltextzugriff (PDF)

Advanced diffusion MRI and image texture analysis detect widespread brain structural differences between relapsing-remitting and secondary progressive multiple sclerosis

Frontiers in human neuroscience, 2022-08, Vol.16, p.944908-944908

2022

Volltextzugriff (PDF)

Advanced Analysis of Diffusion Tensor Imaging Along With Machine Learning Provides New Sensitive Measures of Tissue Pathology and Intra-Lesion Activity in Multiple Sclerosis

Frontiers in neuroscience, 2021-05, Vol.15, p.634063-634063

2021

Volltextzugriff (PDF)

1,25-Dihydroxyvitamin D3 Protects against Immune-Mediated Killing of Neurons in Culture and in Experimental Autoimmune Encephalomyelitis

PloS one, 2015-12, Vol.10 (12), p.e0144084-e0144084

2015

Volltextzugriff (PDF)

Distinct characteristics and severity of brain magnetic resonance imaging lesions in women and men with multiple sclerosis assessed using verified texture analysis measures

Frontiers in neurology, 2023-08, Vol.14, p.1213377-1213377

2023

Volltextzugriff (PDF)

Accounting for uncertainty in training data to improve machine learning performance in predicting new disease activity in early multiple sclerosis

Frontiers in neurology, 2023-05, Vol.14, p.1165267-1165267

2023

Volltextzugriff (PDF)

Good multiple sclerosis (MS) care and how to get there in Canada: Perspectives of Canadian healthcare providers working with persons with MS

Frontiers in neurology, 2023-03, Vol.14, p.1101521-1101521

2023

Volltextzugriff (PDF)

The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design

BMC neurology, 2021-10, Vol.21 (1), p.1-418, Article 418

2021

Volltextzugriff (PDF)

Expression of risk genes linked to vitamin D receptor super-enhancer regions and their association with phenotype severity in multiple sclerosis

Frontiers in neurology, 2022-12, Vol.13, p.1064008-1064008

2022

Volltextzugriff (PDF)

Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators

Journal of the neurological sciences, 2007-08, Vol.259 (1), p.79-84

2007

Volltextzugriff (PDF)

Reduction of microglial activity in a model of multiple sclerosis by dipyridamole

Journal of neuroinflammation, 2013-07, Vol.10 (1), p.89-89, Article 855

2013

Volltextzugriff (PDF)

Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort study

PloS one, 2015-04, Vol.10 (4), p.e0123824-e0123824

2015

Volltextzugriff (PDF)

Discriminative ability of quality of life measures in multiple sclerosis

Health and quality of life outcomes, 2017-12, Vol.15 (1), p.246-246, Article 246

2017

Volltextzugriff (PDF)

Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome

World journal of gastroenterology : WJG, 2018-10, Vol.24 (37), p.4217-4223

2018

Volltextzugriff (PDF)

Psychotic disorders in MS: population-based evidence of an association

Neurology, 2005-10, Vol.65 (7), p.1123

2005

Volltextzugriff (PDF)

Epigenetic changes in patients with multiple sclerosis

Nature reviews. Neurology, 2013-01, Vol.9 (1), p.35

2013

Volltextzugriff (PDF)

Biomarkers of intestinal barrier function in multiple sclerosis are associated with disease activity

Multiple sclerosis, 2020-10, Vol.26 (11), p.1340-1350

2020

Volltextzugriff (PDF)

Point prevalence and correlates of depression in a national community sample with multiple sclerosis

General hospital psychiatry, 2014-05, Vol.36 (3), p.352-354

2014

Volltextzugriff (PDF)

Clinically Isolated Syndrome and Early Relapsing Multiple Sclerosis

Continuum (Minneapolis, Minn.), 2019-06, Vol.25 (3), p.670

Metz, Luanne M

2019

Volltextzugriff (PDF)

Hydroxychloroquine for Primary Progressive Multiple Sclerosis

Annals of neurology, 2021-12, Vol.90 (6), p.940-948

2021

Volltextzugriff (PDF)

Multiple Sclerosis Clinic Utilization is Associated with Fewer Emergency Department Visits

Canadian journal of neurological sciences, 2022-05, Vol.49 (3), p.393-397

2022

Volltextzugriff (PDF)

Adherence of Adolescents to Multiple Sclerosis Disease-Modifying Therapy

Pediatric neurology, 2009-08, Vol.41 (2), p.119-123

2009

Volltextzugriff (PDF)

Effective treatment of progressive MS remains elusive

The Lancet (British edition), 2018-03, Vol.391 (10127), p.1239-1240

2018

Volltextzugriff (PDF)

Depression in multiple sclerosis: A long-term longitudinal study

Multiple sclerosis, 2015-01, Vol.21 (1), p.76-82

2015

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(107)

Publikationsform

Sprache

Englisch
(130)
Japanisch
(11)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis

Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"

Advanced diffusion MRI and image texture analysis detect widespread brain structural differences between relapsing-remitting and secondary progressive multiple sclerosis

Advanced Analysis of Diffusion Tensor Imaging Along With Machine Learning Provides New Sensitive Measures of Tissue Pathology and Intra-Lesion Activity in Multiple Sclerosis

1,25-Dihydroxyvitamin D3 Protects against Immune-Mediated Killing of Neurons in Culture and in Experimental Autoimmune Encephalomyelitis

Distinct characteristics and severity of brain magnetic resonance imaging lesions in women and men with multiple sclerosis assessed using verified texture analysis measures

Accounting for uncertainty in training data to improve machine learning performance in predicting new disease activity in early multiple sclerosis

Good multiple sclerosis (MS) care and how to get there in Canada: Perspectives of Canadian healthcare providers working with persons with MS

The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design

Expression of risk genes linked to vitamin D receptor super-enhancer regions and their association with phenotype severity in multiple sclerosis

Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators

Reduction of microglial activity in a model of multiple sclerosis by dipyridamole

Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort study

Discriminative ability of quality of life measures in multiple sclerosis

Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome

Psychotic disorders in MS: population-based evidence of an association

Epigenetic changes in patients with multiple sclerosis

Biomarkers of intestinal barrier function in multiple sclerosis are associated with disease activity

Point prevalence and correlates of depression in a national community sample with multiple sclerosis

Clinically Isolated Syndrome and Early Relapsing Multiple Sclerosis

Hydroxychloroquine for Primary Progressive Multiple Sclerosis

Multiple Sclerosis Clinic Utilization is Associated with Fewer Emergency Department Visits

Adherence of Adolescents to Multiple Sclerosis Disease-Modifying Therapy

Effective treatment of progressive MS remains elusive

Depression in multiple sclerosis: A long-term longitudinal study

Suchergebnisse filtern